Skip to main content

Imunon, Inc.

IMNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000749647

In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Imunon, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of IMNN: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders1718+1
Shares399.7K412.5K+12.8K (+3.2%)
Value$515.1K$402.9K−$112.2K (−21.8%)

New holders (2)

Institutions that held Imunon, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to IMNN in Q3 2023
InstitutionSharesValue% of portfolio
JPMorgan Chase & Co11$110.00%
FMR LLC6$60.00%

Sold out (1)

Institutions that held Imunon, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of IMNN in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
NewSquare Capital LLC10$13